Literature DB >> 3115762

Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells.

C J Hsu1, J M Hammond.   

Abstract

The observation that GH deficiency delays the onset of puberty has raised the question of the effect of GH on gonadal development. In addition, recent studies in the rat have indicated that GH is able to elevate ovarian levels of immunoreactive insulin-like growth factor I (iIGF-I) in vivo and enhance FSH-induced granulosa cell differentiation in vitro. To evaluate further the possibility of direct effects of GH on ovarian function, we have studied the action of GH on the secretion of iIGF-I and progesterone by cultured porcine granulosa cells from immature follicles. The effects of GH were compared with those of estradiol (E2) and FSH, hormones previously shown to stimulate steroidogenesis and iIGF-I production in this system. GH-stimulated cultures secreted 7.8 times as much iIGF-I per cell as control cultures, while cultures treated with E2 plus FSH secreted 4.5 times as much, and the combination of all three hormones produced an additional increment. The GH-dependent immunoreactivity was localized to two peaks on gel filtration which coeluted with authentic IGF-I and with an IGF-binding protein. In contrast to the results with iIGF-I secretion, GH was a relatively ineffective stimulator of progesterone secretion, resulting in levels 2.6 times the control value, compared to levels 7.4-fold the control value in cultures treated with E2 plus FSH. However, when the three agonists were combined, a synergistic interaction was observed which resulted in progesterone values 33.3 times the control value. In parallel studies, PRL was unable to mimic the effects of GH on iIGF-I or progesterone secretion. In summary, GH has direct stimulatory actions on porcine granulosa cells. Compared to E2 and FSH, established stimulators of these cells, GH is at least comparable in effectiveness with regard to iIGF-I secretion, but less effective as a stimulator of steroidogenesis. However, GH dramatically enhances the effects of E2 and FSH on progesterone secretion. These effects of GH could be important during the onset of puberty, when GH levels in plasma are elevated.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3115762     DOI: 10.1210/endo-121-4-1343

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Growth hormone (GH) and reproduction: a review.

Authors:  F Le Gac; O Blaise; A Fostier; P Y Le Bail; M Loir; B Mourot; C Weil
Journal:  Fish Physiol Biochem       Date:  1993-07       Impact factor: 2.794

Review 3.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

4.  The in vitro development of mouse embryos beyond the blastocyst stage into the hatching and outgrowth stage using different energy sources.

Authors:  P Drakakis; D Loutradis; S Milingos; R Bletsa; K Kallianidis; S Michalas; D Aravantinos
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

Review 5.  Growth hormone for in vitro fertilisation (IVF).

Authors:  Akanksha Sood; Gadha Mohiyiddeen; Gaity Ahmad; Cheryl Fitzgerald; Andrew Watson; Lamiya Mohiyiddeen
Journal:  Cochrane Database Syst Rev       Date:  2021-11-22

Review 6.  Growth hormone for in vitro fertilization.

Authors:  James Mn Duffy; Gaity Ahmad; Lamiya Mohiyiddeen; Luciano G Nardo; Andrew Watson
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

Review 7.  Different ovarian stimulation protocols for women with diminished ovarian reserve.

Authors:  D Loutradis; P Drakakis; E Vomvolaki; A Antsaklis
Journal:  J Assist Reprod Genet       Date:  2007-11-22       Impact factor: 3.412

8.  General health status and intelligence scores of children of mothers with acromegaly do not differ from those of healthy mothers.

Authors:  Ozlem Haliloglu; Burak Dogangun; Bahar Ozcabi; Hanife Ugur Kural; Fatma Ela Keskin; Hande Mefkure Ozkaya; Fatma Colkesen Pamukcu; Elif Bektas; Burc Cagri Poyraz; Hakan Buber; Olcay Evliyaoglu; Pinar Kadioglu
Journal:  Pituitary       Date:  2016-08       Impact factor: 4.107

9.  Growth hormone co-treatment within a GnRH agonist long protocol in patients with poor ovarian response: a prospective, randomized, clinical trial.

Authors:  Tansu Kucuk; Hakan Kozinoglu; Ayten Kaba
Journal:  J Assist Reprod Genet       Date:  2008-04       Impact factor: 3.412

Review 10.  Management of poor responders in IVF: is there anything new?

Authors:  Filippo Ubaldi; Alberto Vaiarelli; Rosario D'Anna; Laura Rienzi
Journal:  Biomed Res Int       Date:  2014-07-20       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.